Across TCGA pan-cancer cohorts, VWDE Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated VWDE data layer compared with 20 for mass-spec protein and 3 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher VWDE Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated VWDE expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
UCEC, KICH, and LIHC are the cancer types where VWDE Mutation most reproducibly stratifies survival.